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Hereditary coproporphyria, a form of acute hepatic porphyria, is a rare
Mendelian autosomaldominantinheritedconditionwithincompletepenetrance.
The acute attack is usually followed by complete remission, but death may
occur. Latent cases are recognised, and the characteristic neurovisceral
symptoms and signs are shared by many other conditions. Acute porphyria
should be considered in the differential diagnosis ofany patient presenting with
abdominal pain and neuropsychiatric upset.
CASEREPORT. A21 yearoldfemalepresentedwith a oneweekhistoryof"'flu-
like" illness, characterised bydrycough, generalizedweakness andsorethroat.
Five days prior to her admission she had developed crampy central abdominal
pain, which radiated to both loins. Trimethoprim was prescribed for a possible
urinary tract infection. Her symptoms did not improve, and she was referred to
her local hospital for investigation.
Examination revealed generalised abdominal tenderness, but no palpable
mass. Bowel sounds were normal. She was apyrexic; blood pressure 140/110
mmHg. Haemoglobin concentration was 14.8 g/dl with normal indices, white
cells 12,000 x 109/l. A routine biochemical profile showed values within the
referencelimitsforsodium, potassium, urea, bilirubinandhepatictransaminases.
Serum calcium was 2.46 mmol/l, glucose 8.3 mmol/l. Routine Stix testing of
urinewas positive forprotein and blood. Urine cultureformicro-organisms was
negative. Ultrasound scan of the abdomen showed right-sided renal agenesis
with hypertrophy of the left kidney. Gastroscopy was reported as normal.
Two days after admission she was found unconscious on the ward. Her blood
pressure was 160/1 10 mmHg, and she had sinus tachycardia of 100 beats per
minute. Fundoscopy revealed retinal artery spasm, but no haemorrhages or
exudates. There were no lateralising signs. She was apyrexic and there was no
neck stiffness. Over the next few hours blood pressure rose to 180/130 mmHg
andpulse rate to 150 beats perminute. Shethen had a generalised tonic-clonic
seizure lasting three minutes, which resolved spontaneously. Intravenous
labetalol wascommenced. Threefurthergeneralised seizuresoccurred overthe
next ten hours. The patient was then referred to our unit at the Royal Victoria
Hospital.
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CT scan of the brain showed no focal lesion. A 24 hour urine collection for
catecholamines was commenced and the specimen was noted to turn a dark
red colour on standing. Catecholamille levels were later reported as normal.
Urine tests for porphyrins revealed d-aminolaevulinic acid 209 gmol/l
(normal=0.8-34.3) and porphobilinogen 316 gmol/l (normal < 8.8). An initial
diagnosis of acute hepatic porphyria was made.
Shewasmanaged conservatively with a 10%dextrose infusion andoral glucose
solutions.' Blood pressure fell to 130/100 mmHg on the labetalol infusion,
which was discontinued when she became normotensive. The second day after
transfershecomplainedoffeelingweak. Physical examinationshowedproximal
muscle power symmetrically reduced to Grade 4 in upper and lower limbs.
Deep tendon reflexes were diminished. Serum sodium was 1 12 mmol/l, and
plasma osmolality 236 mOsm/kg, with urinary sodium 27 mmol/l, and urine
osmolality 542 mOsm/kg. These findings suggested the syndrome of
inappropriate ADH secretion. Fluid restriction to 1000 ml per24 hours returned
the serum sodium level tonormal within five days. Recovery overthe nextweek
included one episode of syncope, but was otherwise uneventful. She was
discharged after sixteen days in hospital.
Subsequentresultsshowedanexcessofbothcoproporphyrin andprotoporphyrin
in a faecal sample, which confirmed a diagnosis ofhereditary coproporphyria.
Herparentsandthreeyoungerbrothersarecurrentlybeing investigated inorder
to detect any latent cases of porphyria.
DISCUSSION
The porphyrias are a heterogeneous group of inborn errors of metabolism
caused by enzyme defects in the biosynthetic pathway of haem. The acute
clinicalpictureoccurssecondarytotheover-productionofporphyrinprecursors.
These disorders are classified into acute and non-acute forms.
Theacuteporphyrias includeacute intermittentporphyria, variegate porphyria,
hereditary coproporphyria and plumboporphyria. All are inherited in an
autosomal dominant fashion with the exception of plumboporphyria, which is
autosomal recessive. Acute attacks may be precipitated by infection, alcohol,
endogenous hormones and a variety of commonly used drugs, particularly
thosewhich areinducersofhepaticmicrosomalenzymes.23Inplumboporphyria,
heterozygotes are liable to illness after moderate exposure to lead.7 Excretion
of porphyrins in the urine is markedly increased in the acute phase, and can
remain so for months afterwards. Faecal analysis is required to classify the
biochemical subtype.
Hereditary coproporphyriawasfirstdescribed in 1955by BerqerandGoldberg.4
There is reduced coproporphyrinogen oxidase activity. The clinical
manifestations are accompanied by the excretion of d-aminolaevulinate and
porphobilinogen in urine and coproporphyrinogen III in faeces and urine.
Genetic studies haveshownthedefecttobe locatedon chromosome9. Arecent
paper5 reports an amino-acid substitution (Arg to Trp) resulting from a single
base change, in a patient homozygous for hereditary coproporphyria. This is
the first mutation that has been found in this condition. Similar methodology
may be used in the future to determine the spectrum of mutations responsible
for hereditary coproporphyria and could be used for diagnostic purposes.
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The acute attack is managed with supportive therapy and a high carbohydrate
intake. In severe cases infusions of haem arginate and tin protoporphyrin may
be given. This induces a rapid biochemical remission.6 They are thought to
work by suppressing the rate-determining enzyme in haem biosynthesis as it
repletesthehepatic poolofhaem. During the recovery phase patientandfamily
education are vital. It is necessary to supply the patient and their general
practitioner with a list of drugs which must be avoided.7 Essential too is the
screening for latent cases amongst the relatives.
A large number ofthe classical clinical features found acutely with this disease
were illustrated in this case. It is interesting that there was no evidence of any
dermatological complaint. Approximately one-third ofpatients with hereditary
coproporphyria will develop a photosensitive bullous skin eruption,8 and these
often have abnormal liverfunction tests, which were not found in this case. Our
patient has nevertheless been counselled regarding possible problems on
exposure to the sun; the use of a sun-block cream may be required.
We were unable to determine the precipitant leading to the development ofthis
particular crisis. It is tentatively suggested that the preceding "'flu-like" illness
or the initial trimethoprim therapy may have been responsible.
We acknowledge the assistance ofthe Department of Biochemistry at The University Hospital of
Wales, Cardiff, with diagnostic faecal analysis, and are grateful to Dr L J E W Walker of the Mid-
Ulster Hospital, Magherafelt, for referring the patient.
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